期刊文献+

聚氨酯-BaFe_(12)O_(19)复合型微粒栓塞材料的血液相容性研究 被引量:1

Blood Compatibility of Polyurethane-BaFe_(12)O_(19) Magnetic Composite Microsphere—a New Material for Endovascular Embolization
下载PDF
导出
摘要 目的探讨包裹聚氨酯的聚氨酯-BaFe12O19复合型磁性微粒栓塞材料作为一种新开发的具有潜在应用前景的新型血管内栓塞材料的血液相容性。方法对聚氨酯-BaFe12O19复合微粒材料进行一系列血液相容性实验,包括溶血实验、出血和凝血时间测定、凝血功能实验等。结果聚氨酯-BaFe12O19复合微粒材料对出血和凝血时间无显著性影响,不引起溶血和凝血功能的改变。结论聚氨酯-BaFe12O19复合型微粒栓塞材料具有良好的血液相容性。 Objective To investigate the blood compatibility of polyurethane-BaFe12O19 magnetic composite microsphere as a new material for endovascular embolization. Methods The blood compatibility of polyurethane-BaFe12O19 particle was evaluated by in vitrod hemolysis test performed in the blood of a voluntary blood donor, coagulation function test in Wistar rats, bleeding time and clotting time tests in Kunming mice. Results The composite material did not cause hemolysis or any changes of coagulation and exhibited no influence on bleeding time and clotting time. Conclusion The blood compatibility of polyurethane-BaFe12O19 megnetic composite material is up to the standardization.
出处 《华南国防医学杂志》 CAS 2007年第6期7-9,共3页 Military Medical Journal of South China
基金 湖北省卫生科研基金重点项目(2003JX1A19)
关键词 聚氨酯-BaFe12O19微粒 栓塞材料 血液相容性 Polyurethane-BaFe12O19 Embolization material Biocompatibility
  • 相关文献

参考文献8

  • 1[1]ISO.Impalnts for surgery-biocompatibility-selection of biological test methods for materials and devices[S].ISO/TR 9966-1989
  • 2[2]ASTM F1748-82.Annual Book of ASFM Standards[J].Medical Devices,1983,13:282
  • 3徐原恩.卫生毒理学基础[M].北京:北京医科大学、中国协和医科大学联合出版社,1991.65-66.
  • 4[5]Turjman F,Massound TF,Vinters HV,et al.Collagen microbeads:experimental evaluation of an embolic agent in the rete mirabile of the swine[J].AJNR,1995,16(5):1031-1036
  • 5赵成如,夏毅然,罗西友,刘作勤,刘文冰.介入医学栓塞材料[J].山东生物医学工程,2002,21(3):54-57. 被引量:13
  • 6[7]Brothers MF,Kaufmann JC,Fox AJ,et al.N-butyl 2-cyanoacrylate substitute for IBCA in interventional neuroradiology:histopathologic and polymerization time studies[J].AJNR 1989,10(4):777-786
  • 7[8]Nakstad PH,Bakke SJ,Hald JK.Embolization of intracranial arteriovenous malformations and fistulas with polyvinyl alcohol particles and platinum fibre coils[J].Neuroradiology,1992,34(4):348-351
  • 8[9]Johnson HJ.Biocompatibility test procedures for materials evaluation in vitro.I.Comparative test system sensitivity[J].J Biomed Mater Res,1983,17(4):571-586

二级参考文献3

共引文献14

同被引文献9

  • 1曹国文,邬书本,邓士杰,李树南,胡罗建,李山云.3种不同支气管动脉栓塞方法治疗大咯血的疗效比较[J].解放军医学杂志,2006,31(6):619-621. 被引量:8
  • 2[1]Barben J,Robertson D,Olinsky A,et al.Bronchial artery embolization for hemoptysis in young patients with cystic fibrosis[J].Radiology,2002,224 (1):124-130
  • 3[3]Brinson GM,Noone PG,Mauro MA,et al.Bronchial artery embolization for the treatment of hemoptysis in patients with cystic fibrosis[J].Am J Respir Crit Care Med,1998,157(6Pt1):1951-1958
  • 4[4]Tamura S,Kodama T,Otsuka N,et al.Embolotherapy for persistent hemoptysis:the significance of pleural thickening[J].Cardiovasc Intervent Radiol,1993,16(2):85-88
  • 5[5]Wong ML,Szkup P,Hopley MJ,et al.Percutaneous embolotherapy for life-threatening hemoptysis[J].Chest,2002,121(1):95-102
  • 6[6]Chun HJ,Byun JY,Yoo SS,et al.Added benefit of thoracic aortography after transarterial embolization in patients with hemoptysis[J].AJR Am J Roentgenol,2003,180 (6):1577-1581
  • 7[7]Yoon W,Kim JK,Kim YH,et al.Bronchial and nonbronchial systemic artery embolization for life-threatening hemoptysis:a comprehensive review[J].Radiographics,2002,22(6):1395-1409
  • 8[8]Planquette B,Bagan P,Cox A,et al.Massive hemoptysis:Successful treatment with surgical ligation of the thyrocervical artery[J].J Thorac Cardiovasc Surg,2007,133(4)1106-1108
  • 9[10]Bruzzi J,Rémy-Jardin M,Delhaye D,et al.Multi-Detector Row CT of Hemoptysis[J].Radiographics,2006,26(1):3-22

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部